Major consultation to strengthen UK’s £100 billion design sector
A major Government consultation launched today by the UK Intellectual Property Office (UKIPO) aims to modernize Britain's design protection system and strengthen the UK's position as a global design powerhouse. Industry analysis estimates that the design sector...
Patent law and AI: the Supreme Court considers Emotional Perception AI’s appeal
Last month, the Supreme Court hearing in the Emotional Perception case took place. Emotional Perception AI Limited (EPL)'s invention was an improved system for providing media file recommendations (such as music) using a trained artificial neural network (ANN), where...
Written description and genus claims: lessons from In re: BAC IP B.V.
On August 5, 2025, in In re: BAC IP B.V., No. 24-2124, the Court of Appeals for the Federal Circuit (CAFC) affirmed the rejection of broad genus claims for lack of written description under 35 U.S.C. § 112, first paragraph. The opinion underscores that satisfying the...
Kubota wins jurisdictional challenge in patent dispute
Background This dispute revolves around a patent infringement case, CS (Comm) 655/2023, filed by Kubota Corporation (Kubota) against Godabari Agro Machinery and Services India Private Limited (GAMS) and two Chinese companies that allegedly manufactured the machine and...
Contours of Section 104A of the Indian Patent Act: burden of proof in case of suits concerning infringement
F. Hoffmann-La Roche AG (Roche), the Plaintiff, has brought a patent infringement suit against Zydus Lifesciences (Zydus), the Defendant. Roche seeks relief from the permanent injunction restraining infringement of the following two Indian patents: Product...
Delhi High Court denies AbbVie’s anti-cMet ADC patent
This article discusses an appeal filed by AbbVie Biotherapeutics Inc. and AbbVie Inc. (Appellants) at the Delhi High Court against the refusal of their patent application (Application No. 201817047767) for an anti-cMet antibody-drug conjugate by the Assistant...
UPC and EPO diverge on inventive step: lessons from Amgen’s PCSK9 patent battle
In a landmark test of the new Unified Patent Court (UPC), the European patent landscape faces a striking divergence between the UPC and the European Patent Office (EPO) on the issue of inventive step. The dispute centers on Amgen's European patent EP 3 666 797, which...
Therapeutic efficacy is a must for a novel intermediate compound to overcome Section 3(d) objection
In an appeal case between Zeria Pharmaceutical Co. Ltd., v. The Controller of Patents (C.A.(COMM.IPD-PAT) 452/2022) before the Delhi High Court, wherein the appellant - a Japanese Corporation - filed an Indian Patent Application, numbered 3630/DLNP/2011 (the subject...
Should translation requirements apply equally in patent law?
A recent High Court judgment in India highlights a potential procedural fairness question in patent examination regarding English translation standards. While patent applicants face rigorous translation requirements under multiple Patent Rules, with severe...
UPC validates second medical use patent in Sanofi v. Amgen antibody therapeutics ruling, finds non-infringement
The Düsseldorf Local Division of the Unified Patent Court (UPC) has handed down a key decision in UPC CFI 505/2024, affirming the validity of a second medical use patent owned by Regeneron and licensed to Sanofi. The case involved alleged infringement by Amgen’s PCSK9...
Annual Report 2024 of the Boards of Appeal of the European Patent Office
The Annual Report 2024 of the Boards of Appeal of the European Patent Office has been published today. It is available in English, German, and French on the Boards' website. Delivering decisions of the highest quality continued to be a central priority in 2024. As in...
Certainty for businesses and choice for consumers as UK maintains IP rights regime
No legislative changes mean businesses can continue operating under the existing exhaustion of intellectual property rights regime without any new requirements. The UK+ regime protects creators and innovators while ensuring fair competition in the marketplace and...
Crystal Crop v. Safex: Delhi High Court on Doctrine of Equivalents and prosecution history estoppel in patent disputes
In Crystal Crop Protection Ltd. v. Safex Chemicals India Ltd. & Ors., CS(COMM) 196/2024, Neutral Citation: 2025:DHC:3382, decided on May 7, 2025 by Hon’ble Mr Justice Amit Bansal of the Delhi High Court, the court refused to grant an interim injunction, holding...
Intellectual Property Salary Survey 2025
Caselton Clark shares a special edition of its 2025 Intellectual Property Salary Survey, providing a comprehensive analysis of salary and benefits trends over the past 10 years. The report covers various levels of seniority across the UK and parts of Europe. To access...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.